Videos

Joseph Alvarnas, MD, a recent presenter at the Association of Community Cancer Centers annual meeting, discussed efforts to implement biosimilars at City of Hope, a clinical research center, hospital, and graduate medical school in Duarte, California.

Lalan Wilfong, MD, an expert on value-based care, explains how Texas Oncology worked with physicians and payers to make biosimilars available for patients.

Here are the top 5 biosimilar articles for the week of March 1, 2021.

Here are the top 5 biosimilar articles for the week of February 22, 2021.

Huiya Wu, JD, and Freddy Yip, PhD, PCLL, attorneys at Goodwin Procter, discussed projections for the Chinese biosimilars market and the potential for foreign companies to get a share.

Here are the top 5 biosimilar articles for the week of February 15, 2021.

Huiya Wu, JD, and Freddy Yip, PhD, PCLL, attorneys at Goodwin Procter, discussed biologic drug patent laws in China and the US.

Here are the top 5 biosimilar articles for the week of February 8, 2021.

Steven Lucio, PharmD, BCPS, vice president of Pharmacy Solutions for Vizient, discussed Vizient’s forecast for adalimumab price increases and the market implications of high-concentration adalimumab.

Here are the top 5 biosimilar articles for the week of February 1, 2021.

HoUng Kim, PhD, head of the Medical and Marketing Division at Celltrion Healthcare, discusses how the company’s adalimumab biosimilar candidate, CT-P17, stands out from the competition.

Here are the top 5 biosimilar articles from SABCS 2020.

Here are the top 5 biosimilar articles for the week of January 25, 2021.

Charles Bennett, MD, PhD, a hematologist, oncologist, and professor at the University of South Carolina, explained the many sticking points that prevent biosimilar savings.

Here are the top 5 biosimilar articles for the week of January 18, 2021.

Here are the top 5 biosimilar articles for the week of January 11, 2021.

Charles Bennett, MD, PhD, a hematologist and oncologist and professor in the Clinical Pharmacy and Outcomes Sciences Department of the College of Pharmacy at the University of South Carolina, discussed the FDA’s pace of biosimilar approvals and the findings from his recent study.

Here are the top 5 biosimilar articles for the week of January 4, 2021.

Ivo Abraham, PhD, RN, a professor with the University of Arizona Health Sciences in the Department of Pharmacy Practice and a health care consultant and co-founder of Matrix45, discussed how the pandemic is likely to impact the use of pegfilgrastim biosimilars.

Here are some of our most-listened-to 2020 "Not So Different" podcasts.

Here are some of our most-popular biosimilar interviews for all of 2020.

Ivo Abraham, PhD, RN, a professor in the Department of Pharmacy Practice at University of Arizona Health Sciences, and a health care consultant with Matrix45, discusses recent studies that demonstrated savings for pegfilgrastim vs the on-body injector.

Here are the top 5 biosimilar articles for the week of December 14, 2020.

We sat down with Jennifer Snow, MPH, vice president of Reimbursement and Policy Insights at Xcenda, to talk about health care reform efforts and how these would be affected by the change in administration.

Here are the top 5 biosimilar articles for the week of December 7, 2020.

Robert Rifkin, MD, FACP, oncologist and hematologist with Rocky Mountain Cancer Centers and medical director of Biosimilars for McKesson, discusses how his practice is working to correct biosimilar education gaps among physicians and the consequences if those gaps are not addressed.

Here are the top 5 biosimilar articles for the week of November 30, 2020.

Jorge Garcia, PharmD, MS, MHA, MBA, assistant vice president of the System Oncology Pharmacy Service Line at Baptist Health South Florida, discussed how Baptist Health increases biosimilar use and how innovator companies fight to avoid biosimilar competition.

Here are the top 5 biosimilar articles from the American College of Rheumatology (ACR) Convergence 2020.

Here are the top 5 biosimilar articles for the week of November 16, 2020.